Related Experiment Video
Updated: Apr 8, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Multi-Omics Integration in Urological Cancers: Unlocking Precision Diagnosis and Therapy Through Big Data
Charlotte Delrue1, Marijn M Speeckaert1,2
1Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
Multi-omics integration refines urological cancer subtypes and identifies biomarkers for better precision. Overcoming data challenges is key to translating these advances into clinical practice for improved patient outcomes.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Urological cancers (prostate, bladder, renal) present significant global health challenges due to molecular heterogeneity.
- Single-omics approaches offer limited insights, hindering biomarker robustness and therapeutic precision.
- Multi-omics integration provides a systems-level view of cancer biology, crucial for understanding complex regulatory networks.
Purpose of the Study:
- To review recent literature on multi-omics integration in urological cancers.
- To synthesize findings on the application of multi-omics in understanding and managing prostate, bladder, and renal cancers.
- To identify challenges and future directions for clinical implementation.
Main Methods:
- Comprehensive narrative review of English-language, peer-reviewed studies published before September 2025.
- Searched PubMed, Scopus, and Web of Science databases.
- Synthesized findings from studies utilizing genomics, transcriptomics, proteomics, metabolomics, epigenomics, and computational integration frameworks (e.g., machine learning, graph neural networks, stemness-based classifiers, spatial multi-omics).
Main Results:
- Multi-omics integration refines molecular subtypes and identifies prognostic/predictive biomarkers in prostate, bladder, and renal cancers.
- Examples include stemness classifiers in prostate cancer, consensus molecular subtypes in bladder cancer, and cell death signatures in renal cancer.
- Persistent challenges include data heterogeneity, small cohort sizes, lack of standardized pipelines, and translational gaps.
Conclusions:
- Multi-omics integration is transitioning from research to a core component of precision urology.
- Mechanistically grounded, interpretable models hold potential for improved individualized diagnosis, prognostication, and therapy selection.
- Clinical translation requires addressing limitations via standardization, collaborative efforts, and explainable artificial intelligence.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
08:40Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
Published on: April 8, 2016